The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
Abstract
Because of the pathological role of IL-6 in rheumatoid arthritis (RA), tocilizumab (TCZ), a humanized anti-IL-6 receptor monoclonal antibody, was expected to improve inflammation and joint destruction of RA. Indeed, randomized clinical trials demonstrated the clinical efficacy of TCZ as monotherapy or combined with methotrexate (MTX) for RA patients with inadequate responses to disease-modifying antirheumatic drugs, MTX or tumor necrosis factor (TNF) inhibitors. Although long-term tolerability for TCZ is superior to that for TNF inhibitors, information regarding the potency of drug free remission of TCZ is limited at present. In terms of its safety profile, the general risk of infection when using TCZ is comparable to that of TNF inhibitors. TCZ has some advantage in RA patients who can not use MTX and are non-responders to TNF inhibitors. In conclusion, TCZ is one of the most prospective next generation biologics for the treatment of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tocilizumab showed protective efficacy against joint destruction and suppressed disease activity (Ogata et al., 2012”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as Ogata et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationKishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092932 · Cited by 1,104
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Gómez‐Reino, J. J., Carmona, L., Valverde, V. R., Mola, E. M., & Montero, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11137 · Cited by 1,013
New therapies for treatment of rheumatoid arthritis
Smolen, J. S., Aletaha, D., Koeller, M., Weisman, M. H., & Emery, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60784-3 · Cited by 995
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Adverse effects of biologics: a network meta-analysis and Cochrane overview
Singh, J. A., Wells, G. A., Christensen, R., Tanjong Ghogomu, E., Maxwell, L. J., MacDonald, J. K., Filippini, G., Skoetz, N., Francis, D. K., Lopes, L. C., et al. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008794.pub2 · Cited by 823
Jones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797
Nishimoto, N., Terao, K., Mima, T., Nakahara, H., Takagi, N., & Kakehi, T. (2008) · Blood · doi:10.1182/blood-2008-05-155846 · Cited by 795
Maini, R. N., Taylor, P. C., Szechinski, J., Pavelka, K., Bröll, J., Balint, G., Emery, P., Raemen, F., Petersen, J., Smolen, J., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22033 · Cited by 790
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Hashimoto, J., Azuma, J., & Kishimoto, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20303 · Cited by 788
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Nishimoto, N., Hashimoto, J., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Murata, N., van der Heijde, D., & Kishimoto, T. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068064 · Cited by 727
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Interleukin 6: from bench to bedside
Nishimoto, N., & Kishimoto, T. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0338 · Cited by 642
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Kotake, S., Sato, K., Kim, K. J., Takahashi, N., Udagawa, N., Nakamura, I., Yamaguchi, A., Kishimoto, T., Suda, T., & Kashiwazaki, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110113 · Cited by 545
Hetland, M. L., Christensen, I. J., Tarp, U., Dreyer, L., Hansen, A., Hansen, I. T., Kollerup, G., Linde, L., Lindegaard, H., Poulsen, U. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.27227 · Cited by 538
Choy, E. H. S., Isenberg, D. A., Garrood, T., Farrow, S., Ioannou, Y., Bird, H., Cheung, N., Williams, B., Hazleman, B., Price, R., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10623 · Cited by 526
The roles of IL‐17A in inflammatory immune responses and host defense against pathogens
Iwakura, Y., Nakae, S., Saijo, S., & Ishigame, H. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00699.x · Cited by 513
Palmqvist, P., Persson, E., Conaway, H. H., & Lerner, U. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3353 · Cited by 486
Kremer, J. M., Blanco, R., Brzosko, M., Burgos-Vargas, R., Halland, A.-M., Vernon, E., Ambs, P., & Fleischmann, R. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30158 · Cited by 409
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
Integrated safety in tocilizumab clinical trials
Schiff, M. H., Kremer, J. M., Jahreis, A., Vernon, E., Isaacs, J. D., & van Vollenhoven, R. F. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3455 · Cited by 367
Hashizume, M., Hayakawa, N., & Mihara, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken363 · Cited by 347
Madhok, R., Crilly, A., Watson, J., & Capell, H. A. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.3.232 · Cited by 340
Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., & Azuma, J. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.092866 · Cited by 337
Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Azuma, J., & Kishimoto, T. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0125-1 · Cited by 334
Donahue, K. E., Gartlehner, G., Jonas, D. E., Lux, L. J., Thieda, P., Jonas, B. L., Hansen, R. A., Morgan, L. C., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00192 · Cited by 299
Gomez-Reino, J. J., Carmona, L., & the BIOBADASER Group (2006) · Arthritis Research & Therapy · doi:10.1186/ar1881 · Cited by 289
Campbell, L., Chen, C., Bhagat, S. S., Parker, R. A., & Ostor, A. J. K. (2011) · Rheumatology · doi:10.1093/rheumatology/keq343 · Cited by 282
Nishimoto, N., Miyasaka, N., Yamamoto, K., Kawai, S., Takeuchi, T., Azuma, J., & Kishimoto, T. (2009) · Modern Rheumatology · doi:10.3109/s10165-008-0125-1 · Cited by 268
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Self-citationSchultz, O., Oberhauser, F., Saech, J., Rubbert‐Roth, A., Hahn, M., Krone, W., & Laudes, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014328 · Cited by 229
Functional subsets of CD4 T cells in rheumatoid synovitis
Namekawa, T., Wagner, U. G., Goronzy, J. J., & Weyand, C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2117::aid-art6>3.0.co;2-p · Cited by 220
Kagari, T., Doi, H., & Shimozato, T. (2002) · Journal of Immunology · doi:10.4049/jimmunol.169.3.1459 · Cited by 212
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice
Sasai, M., Saeki, Y., Ohshima, S., Nishioka, K., Mima, T., Tanaka, T., Katada, Y., Yoshizaki, K., Suemura, M., & Kishimoto, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1635::aid-anr11>3.0.co;2-q · Cited by 208
Self-citationGarnero, P., Thompson, E., WOODWORTH, T. G., & Smolen, J. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25053 · Cited by 207
Nishimoto, N., Yoshizaki, K., Maeda, K., Kuritani, T., Deguchi, H., Sato, B., Imai, N., Suemura, M., Kakehi, T., Takagi, N., et al. (2003) · PubMed · Cited by 203
Koike, T., Harigai, M., Inokuma, S., Ishiguro, N., Ryu, J., Takeuchi, T., Takei, S., Tanaka, Y., Ito, K., & Yamanaka, H. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.151092 · Cited by 196
Nakajima, A., Inoue, E., Tanaka, E., Singh, G., Sato, E., Hoshi, D., Shidara, K., Hara, M., Momohara, S., Taniguchi, A., et al. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009741003604542 · Cited by 167
Nishimoto, N., Ito, K., & Takagi, N. (2010) · Modern Rheumatology · doi:10.1007/s10165-010-0279-5 · Cited by 165
Burmester, G. R., Feist, E., Kellner, H., Braun, J., Iking‐Konert, C., & Rubbert‐Roth, A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.139725 · Cited by 164
Yazıcı, Y., Curtis, J. R., Ince, A., Baraf, H. S. B., Malamet, R., Teng, L. L., & Kavanaugh, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148700 · Cited by 155
Hyrich, K. L., Symmons, D. P. M., Watson, K. D., Silman, A. J., & British Society for Rheumatology Biologics Register (2006) · Arthritis & Rheumatism · doi:10.1002/art.21830 · Cited by 144
Salliot, C., Finckh, A., Katchamart, W., Lu, Y., Sun, Y., Bombardier, C., & Keystone, E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132134 · Cited by 140
Leffers, H. C. B., Østergaard, M., Glintborg, B., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140129 · Cited by 126
Gout, T., Östör, A. J. K., & Nisar, M. K. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1827-x · Cited by 125
Nishimoto, N., Ito, K., & Takagi, N. (2010) · Modern Rheumatology · doi:10.3109/s10165-010-0279-5 · Cited by 113
Bergman, G., Hochberg, M., Boers, M., Wintfeld, N., Kielhorn, A., & Jansen, J. (2010) · Seminars in Arthritis & Rheumatism · doi:10.1016/j.semarthrit.2009.12.002 · Cited by 109
Tocilizumab for rheumatoid arthritis
Singh, J. A., Beg, S., & Lopez-Olivo, M. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008331.pub2 · Cited by 95
Ogata, A., Morishima, A., Hirano, T., Hishitani, Y., Hagihara, K., Shima, Y., Narazaki, M., & Tanaka, T. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132845 · Cited by 94
Self-citationMihara, M., Kotoh, M., Nishimoto, N., Oda, Y., Kumagai, E., Takagi, N., Tsunemi, K., Ohsugi, Y., Kishimoto, T., Yoshizaki, K., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4989 · Cited by 93
Yamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2010) · Modern Rheumatology · doi:10.1007/s10165-010-0366-7 · Cited by 93
Tocilizumab for the treatment of rheumatoid arthritis
Tanaka, T., Ogata, A., & Narazaki, M. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.70 · Cited by 92
Self-citationTakeuchi, T., Tanaka, Y., Amano, K., Hoshi, D., Nawata, M., Nagasawa, H., Sato, E. I., Saito, K., Kaneko, Y. S., Fukuyo, S., et al. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker221 · Cited by 88
Hirao, M., Hashimoto, J., Tsuboi, H., Nampei, A., Nakahara, H., Yoshio, N., Mima, T., Yoshikawa, H., & Nishimoto, N. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090068 · Cited by 88
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
Patel, A. M., & Moreland, L. (2010) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14099 · Cited by 80
Enhanced production of interleukin‐6 in mice with type II collagen–induced arthritis
Takai, Y., Seki, N., Senoh, H., Yokota, T., Lee, F., Hamaoka, T., & Fujiwara, H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320513 · Cited by 70
Hashizume, M., Yoshida, H., Koike, N., Suzuki, M., & Mihara, M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.104844 · Cited by 68
Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab
Ogata, A., Umegaki, N., Katayama, I., Kumanogoh, A., & Tanaka, T. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.06.011 · Cited by 64
Self-citationYamanaka, H., Tanaka, Y., Inoue, E., Hoshi, D., Momohara, S., Hanami, K., Yunoue, N., Saito, K., Amano, K., Kameda, H., et al. (2011) · Modern Rheumatology · doi:10.3109/s10165-010-0366-7 · Cited by 59
Hirao, M., Yamasaki, N., Oze, H., Ebina, K., Nampei, A., Kawato, Y., Shi, K., Yoshikawa, H., Nishimoto, N., & Hashimoto, J. (2011) · Rheumatology International · doi:10.1007/s00296-011-2135-0 · Cited by 51
Uchiyama, Y., Yorozu, K., Hashizume, M., Moriya, Y., & Mihara, M. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1159 · Cited by 50
Turkstra, E., Ng, S., & Scuffham, P. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.608655 · Cited by 48
Switching rheumatoid arthritis treatments: An update
Atzeni, F., Sarzi‐Puttini, P., Gorla, R., Marchesoni, A., & Caporali, R. F. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.01.001 · Cited by 38
Hoshi, D., Nakajima, A., Inoue, E., Shidara, K., Sato, E., Kitahama, M., Seto, Y., Tanaka, E., Urano, W., Ichikawa, N., et al. (2011) · Modern Rheumatology · doi:10.1007/s10165-011-0488-6 · Cited by 36
Drug-free remission: is it already possible?
van den Broek, M., Huizinga, T. W. J., Dijkmans, B. A. C., & Allaart, C. F. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834563e3 · Cited by 30
Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens
Ogata, A., Mori, M., Hashimoto, S., Yano, Y., Fujikawa, T., Kawai, M., Kuwahara, Y., Hirano, T., Arimitsu, J., Hagihara, K., et al. (2009) · Modern Rheumatology · doi:10.1007/s10165-009-0243-4 · Cited by 28
Self-citationNishimoto, N., Amano, K., Hirabayashi, Y., Horiuchi, T., Ishii, T., Iwahashi, M., Iwamoto, M., Kohsaka, H., Kondo, M., Matsubara, T., et al. (2013) · Modern Rheumatology · doi:10.3109/14397595.2013.854080 · Cited by 27
ORIGINAL ARTICLE: IL‐6 as a Regulatory Factor of the Humoral Response During Pregnancy
Dubinsky, V., Junovich, G., Gentile, T., et al. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00614.x · Cited by 25
Iking‐Konert, C., Aringer, M., Wollenhaupt, J., Mosch, T., Tuerk, S., Feist, E., & Burmester, G. R. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152678 · Cited by 25
Okada, M., Kita, Y., Kanamaru, N., Hashimoto, S., Uchiyama, Y., Mihara, M., Inoue, Y., Ohsugi, Y., Kishimoto, T., & Sakatani, M. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/404929 · Cited by 22
Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens
Ogata, A., Mori, M., Hashimoto, S., Yano, Y., Fujikawa, T., Kawai, M., Kuwahara, Y., Hirano, T., Arimitsu, J., Hagihara, K., et al. (2010) · Modern Rheumatology · doi:10.3109/s10165-009-0243-4 · Cited by 17
Self-citationDougados, M., Kissel, K., Amital, H., Conaghan, P. G., Martín-Mola, E., Nasonov, E. L., Schett, G., Troum, O. M., Veldi, T., Bernasconi, C., et al. (2011) · Data Archiving and Networked Services (DANS) · Cited by 10
Taylor, A., Nash, P. T., Hall, S. M., Jones, G., Youssef, P. P., Porter-Brown, B., Thompson, L., & Genovese, M. C. (2012) · Internal Medicine Journal · Cited by 9
Koike, T., Sano, Y., Tanaka, Y., Takeuchi, T., Takei, S., Ryu, J., Ishiguro, N., Inokuma, S., Harigai, M., & Yamanaka, H. (2011) · Arthritis & Rheumatism · Cited by 2
Research works printed but not linked: 8
- Ogata A., 2011, Joint Bone Spine.
- Nishimoto N., 2003, J Rheumatol., 30, 1426
- Singh J.A., 2010, Cochrane Database Syst Rev., 70, CD008331
- Yazici Y., 2011, Ann Rheum Dis.
- Hoshi D., 2011, Mod Rheumatol.
- Okada M., 2011, Clin Dev Immunol., 404929
- Hirao M., 2011, Rheumatol Int.
- Singh J.A., 2011, Cochrane Database Syst Rev., CD008794
Cited by
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Self-citation
Metadata
- Authors
- Ogata, A., Hirano, T., Hishitani, Y., & Tanaka, T.
- Affiliations
- Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan.
- Venue
- Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
- Publisher
- SAGE Publications
- Published
- 2012-01
- Volume
- 5
- Pages
- CMAMD.S7371
- ISSN
- 1179-5441
- PMC
- PMC3306224
- Cited by
- 61
- References
- 86
- Language
- en
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.